Mason & Associates Inc Acquires Shares of 478 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mason & Associates Inc bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 478 shares of the medical equipment provider’s stock, valued at approximately $235,000.

Several other hedge funds and other institutional investors have also modified their holdings of ISRG. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 51,455 shares of company stock valued at $24,911,155 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 0.0 %

Shares of ISRG traded up $0.11 on Thursday, reaching $512.69. The company’s stock had a trading volume of 190,857 shares, compared to its average volume of 1,469,101. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $523.34. The stock has a market capitalization of $181.85 billion, a PE ratio of 92.52, a PEG ratio of 5.40 and a beta of 1.39. The firm has a fifty day moving average of $486.71 and a 200-day moving average of $440.96.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.